SLGL (Sol-Gel Technologies) ROCE %: -40.59% (As of Mar. 2026)

What is Sol-Gel Technologies ROCE %?

Sol-Gel Technologies SLGL +3.12% 56 ROCE % is -40.59% as of Mar. 2026. GuruFocus rates SLGL with a GF Score™ of 56/100 and a GF Value™ of $65.37 (Modestly Overvalued). The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Sol-Gel Technologies's annualized ROCE % for the quarter that ended in Mar. 2026 was -40.59%.

Sol-Gel Technologies (NAS:SLGL) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Sol-Gel Technologies ROCE % Related Terms

Sol-Gel Technologies ROCE % Historical Data

* Premium members only.

The historical data trend for Sol-Gel Technologies's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sol-Gel Technologies ROCE % Chart

Sol-Gel Technologies Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROCE %

Get a 7-Day Free Trial

5.36

-32.23

-69.72

-33.69

-27.76

Sol-Gel Technologies Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial															-136.76	158.05	-80.10	-52.28	-40.59

56GF Score

Sol-Gel Technologies Ltd SLGL

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Sol-Gel Technologies ROCE % Calculation

Sol-Gel Technologies's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	-7.538	/	( ( (35.846 - 5.285)	+	(29.917 - 6.171) )	/ 2 )
	=	-7.538	/	( (30.561	+	23.746)	/ 2 )
	=	-7.538	/	27.1535
	=	-27.76 %

Sol-Gel Technologies's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	-15.42	/	( ( (29.917 - 6.171)	+	(58.55 - 6.313) )	/ 2 )
	=	-15.42	/	( ( 23.746	+	52.237 )	/ 2 )
	=	-15.42	/	37.9915
	=	-40.59 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of -40.59% mean?

Sol-Gel Technologies (SLGL) has a ROCE % of -40.59% as of Mar. 2026.

Is Sol-Gel Technologies' ROCE % too high?

Sol-Gel Technologies' current ROCE % is -40.59%. Overall, Sol-Gel Technologies has a GF Score™ of 56/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Sol-Gel Technologies' ROCE % compare to ALEC and LENZ?

Sol-Gel Technologies' ROCE % of -40.59% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Biotechnology company?

A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. Sol-Gel Technologies's current ROCE % is -40.59%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Sol-Gel Technologies stock overvalued right now?

Based on GuruFocus' analysis, Sol-Gel Technologies (SLGL) is currently considered Modestly Overvalued. The stock's GF Value™ is $65.37, compared to a current price of $74.40 — trading 13.8% above its estimated fair value. The current ROCE % is -40.59%. Sol-Gel Technologies' overall GF Score™ is 56/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Sol-Gel Technologies (SLGL), the current ROCE % is -40.59% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sol-Gel Technologies (SLGL) Overvalued in 2026?

Based on GuruFocus' analysis, Sol-Gel Technologies stock appears to be overvalued. The current stock price of $74.40 is trading 13.8% above its estimated GF Value™ of $65.37. GuruFocus considers Sol-Gel Technologies to be Modestly Overvalued.

Key valuation signals for SLGL:

ROCE %: -40.59%
GF Value™: $65.37 vs. price of $74.40 (13.8% above fair value)
GF Score™: 56/100 with 2 warning signs

No single metric tells the full story. See the SLGL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sol-Gel Technologies Business Description

Industry Healthcare Biotechnology

Comparable Companies ALEC LENZ CNXU CHRS OBIO CRBU VYGR WHWK NKTX IKT VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges 4SG:Germany

Address 7 Golda Meir Street, Weizmann Science Park, Ness Ziona, ISR, 7403650

Website https://www.sol-gel.com

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.

56GF Score

Get the complete analysis for SLGL

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$74.40

Price

$65.37

GF Value

View SLGL Analysis

See ROCE % data for all stocks →